ARTICLE | Clinical News
Kombiglyze XR saxagliptin/metformin regulatory update
November 8, 2010 8:00 AM UTC
FDA approved an NDA from Bristol-Myers and AstraZeneca for Kombiglyze XR to treat Type II diabetes. Kombiglyze is a fixed-dose combination of once-daily Onglyza saxagliptin and extended-release metfo...